Market evolution: Ostomy appliances (CN 300691) — 2015–2025

Introduction

This report examines the evolution of EU trade in ostomy appliances (customs code 300691, Scope & Definitions) over the period 2015–2025. These medical devices — used by patients who have undergone ostomy surgery — occupy a niche but strategically important segment of the pharmaceutical and medical-device trade. Over the decade, the EU has consolidated its position as the world's leading net exporter of ostomy appliances, with its trade surplus more than tripling. Simultaneously, the import landscape has been reshaped by a dramatic shift in data reporting, the emergence of new supplier countries, and a halving of average import prices. Within the EU, a profound restructuring of manufacturing capacity has occurred, with Hungary rising to dominance as Germany's role receded. Three dynamics — explored in the sections below — capture the essential story of this market.

1. The EU's Consolidation as a Global Export Powerhouse

Exports grew far faster than imports, tripling the trade surplus

Between 2015 and 2025, EU exports of ostomy appliances to non-EU countries rose from €320.4 million to €588.3 million, an increase of 83.6% in value and 67.6% in volume (from 5,253 to 8,803 tonnes) (General Overview — trade). Over the same period, imports grew more modestly in value (+34.4%, from €163.9 million to €220.3 million). The result was a dramatic widening of the EU's trade surplus:

The surplus thus expanded from €156.5 million to €368.0 million (+135.1%). This widening gap underscores the EU's structural competitiveness in this high-value medical-device segment.

Export prices remained stable, signalling a sustained quality premium

EU export unit values hovered between €55,346 and €66,828 per tonne over the period, finishing at €66,828/t in 2025 — a modest increase of 9.6% from 2015. This price stability, in the face of growing volumes, suggests that EU manufacturers have maintained their positioning in the premium segment of the global market. By contrast, as discussed in Section 2, import prices collapsed by nearly half, creating a growing price gap that reflects the different product tiers being traded.

The United Kingdom and the United States anchor the EU's export markets

The top export partners reveal a clear geographic structure. The United Kingdom has consistently been the EU's largest export destination, growing from €132.5 million to €233.3 million (+76.1%), reflecting deep post-Brexit supply-chain integration in the medical-devices sector. The United States saw the most explosive growth, surging from €17.1 million to €84.2 million (+393.5%), making it the second-largest market. Japan (+32.6%), China (+153.1%), and Türkiye (+42.0%) also expanded meaningfully:

Australia was the only top partner to see a decline (−23.3%), while the growth of the US and Chinese markets points to the EU's expanding reach in Asia-Pacific and North America. Export volatility to these partners remained low (Volatility bars), with coefficient-of-variation values between 0.12 (Japan) and 0.39 (United States), confirming the stability of these commercial relationships.

2. A Transformed Import Landscape: New Sources and Collapsing Prices

The disappearance of the 'unspecified' category masks the true scale of import growth

Perhaps the single most consequential data feature is the collapse of the category "Countries and territories not specified for commercial or military reasons." In 2015, this category accounted for €119.7 million — representing 73% of all EU imports in value. By 2025, it had fallen to essentially zero (€36,000). This is not a trade event but a data-reporting and classification change that progressively redistributed previously hidden imports into identifiable partner countries. As a result, the apparent modest growth of 34.4% in total import value dramatically understates the real expansion of identifiable bilateral trade: excluding the "unspecified" category, identifiable imports grew from approximately €44 million in 2015 to €220 million in 2025 — a nearly fivefold increase.

This reclassification also explains the sharp initial drop in import value and quantity (the minimum values — €75.4 million in value and 2,056 tonnes in volume — occurred at an intermediate point during this transition) and the collapse of the import-concentration HHI from 6,395 to 2,401 (−62.4%), which largely reflects the redistribution of a single large "unspecified" block into many smaller, identifiable sources (Concentration HHI).

Latin American and North American suppliers surged to prominence

As the "unspecified" category shrank, several previously marginal suppliers emerged as major import partners for the EU. The most striking cases include:

The United States' surge of nearly 3,500% is particularly notable, likely reflecting the price shock of 2018 — when import unit prices from the US spiked by +221.6% — combined with subsequent volume increases. Costa Rica and the Dominican Republic, both hosts to significant medical-device manufacturing clusters serving the Americas, have become substantial suppliers, with volumes and values rising by over 1,000% each. This geographic diversification is also reflected in the rising volatility of import flows: the coefficient of variation for imports from these newer partners is substantially higher (0.60–0.65) than for established export markets, indicating that these supply relationships are still maturing (Volatility bars).

Import prices were halved while volumes surged, indicating a shift toward lower-cost supply

The most structurally significant price movement occurred on the import side. Average import unit values fell from €38,793 per tonne in 2015 to €19,467 per tonne in 2025, a decline of 49.8%. Over the same period, import volumes rose from 4,226 to 11,318 tonnes (+167.8%). This divergence — collapsing prices amid surging volumes — is consistent with the entry of cost-competitive manufacturers from Central America and Asia into the EU market, as well as the possible reclassification of lower-value product lines under this tariff code. The growing price gap between EU exports (€66,828/t) and imports (€19,467/t) — a ratio of roughly 3.4:1 — suggests the EU is increasingly importing basic or commodity-grade ostomy products while exporting premium, higher-value-added devices.

A price shock from the United Kingdom in 2020 (+184.4% unit-price shift, with 42.4% value share) coincides with the Brexit transition period and may reflect short-term disruption or re-invoicing effects in the UK–EU supply chain.

3. Intra-EU Restructuring: Hungary's Rise and the Decline of Domestic Production

Hungary replaced Germany as the EU's dominant ostomy-exporting nation

The most dramatic structural shift within the EU occurred among member-state exporters (Top reporters — exports). Hungary's extra-EU exports surged from €31.8 million in 2015 to €308.9 million in 2025, an increase of 873%, making it by far the EU's largest exporter of ostomy appliances — accounting for over half of all EU export value. Over the same period, Germany's exports fell from €170.8 million to €51.7 million (−69.7%), relegating it from first to third place. Lithuania also emerged as a significant exporter, growing from €0.5 million to €14.1 million (+2,630%):

Hungary's dominance is further confirmed by specialisation data: in 2025, Hungary held a revealed symmetric comparative advantage (RSCA) of 0.77 and an RCA of 7.59 for ostomy appliances, the second-highest in the EU after Lithuania (RSCA 0.88, RCA 15.05) (Most specialised reporters). Hungary is simultaneously a growing importer (from €2.4 million to €37.7 million, +1,444%), consistent with a hub-and-spoke model in which it imports components or semi-finished goods and re-exports finished devices.

EU production value declined even as exports soared

Despite the strong export performance, reported EU production value fell from €587.3 million to €400.0 million (−31.9%) over the period, with a trough of €304.4 million in an intermediate year. This decline, juxtaposed against the 83.6% growth in export value, points to a structural transformation: EU-based companies may be increasingly relying on contract manufacturing, offshoring, or intra-group imports from non-EU affiliates to serve global demand, while concentrating higher-value-added activities (R&D, branding, logistics) within the bloc. The export propensity metric — which reached 141.9% in 2025 (up from 56.8%) — confirms this: EU exports now significantly exceed domestic production value, implying that a substantial share of exported devices originate from, or incorporate inputs sourced from, outside the EU.

The EU's net-exporter position masks growing external dependence

The net import reliance indicator, deeply negative throughout (from −61.6% to −800.0%), confirms the EU's strong net-exporter status. However, trade intensity doubled from 63.6% to 127.4%, indicating that the EU's ostomy-appliance sector has become far more deeply integrated into global value chains. Combined with the surge in imports from new, higher-volatility suppliers (Costa Rica, Dominican Republic, United States) and the decline in domestic production, this suggests a growing — if currently well-managed — exposure to supply-chain disruption. The export-side concentration remained stable (HHI of ~1,900), but the import-side HHI's sharp decline to 2,401, while indicating diversification, also reflects a more fragmented and potentially less predictable supplier base.

Conclusion

Over the 2015–2025 period, the EU's trade in ostomy appliances (CN 300691) has undergone a triple transformation. First, the EU has consolidated its role as the world's leading net exporter, with its trade surplus more than tripling to €368 million, driven primarily by the United Kingdom and the rapidly growing US market. Second, the import landscape has been fundamentally reshaped: a major data-reporting shift eliminated a large "unspecified" category, revealing a surge of imports from Costa Rica, the Dominican Republic, and the United States, accompanied by a 50% decline in average import prices. Third, within the EU, manufacturing and export capacity have migrated decisively toward Central and Eastern Europe, with Hungary now accounting for more than half of all extra-EU export value — even as overall EU production value has declined by nearly a third.

Together, these trends paint a picture of a sector that is thriving commercially but increasingly reliant on complex, geographically dispersed value chains. For policymakers concerned with medical-device supply security, the key question going forward is whether the EU's impressive export competitiveness can be sustained as its domestic production base continues to shrink and its dependence on newer, more volatile import sources grows.